Annual Clinical and Scientific Conference 2018

June 26-29, 2018 in Victoria, British Columbia

Program is subject to changes.

Click here to view the week-at-a-glance.

Please note that events are taking place at a number of venues For easy reference, use this legend to help find your way:
V - Victoria Conference Centre
F -  Fairmont Empress

 

There is no food or beverage permitted in the lecture theatre (all plenary sessions).

Photo of Guy-Paul  Gagné

Biography

Dr Guy-Paul Gagné MD

Montreal QC
Dr Gagné is currently MOREOB (Managing Obstetrical Risks Efficiently) Program Director for the province of Québec in collaboration with the Society of Obstetricians and Gynaecologists of Canada (SOGC). He graduated from Sherbrooke University Faculty of Medicine and from McGill University in Obstetrics and Gynaecology. He is an Assistant Professor in the Department of Obstetrics and Gynaecology, Faculty of Medicine, McGill University.

His previous positions include: Director of Obstetrics and Gynaecology at LaSalle General Hospital (Montreal) and Coordinator of the Teaching and Continual Medical Education Program for 16 years. He has 30 years of experience in clinical practice, teaching and research in maternity care. He collaborated with Health Canada and the Canadian Institute of Child Health in the writing and reviewing of the Family-Centered Maternity and Newborn Care-National Guidelines, 4th Edition, a document to assist hospitals and other health care agencies in the planning of maternal and newborn programs and services. As a former member and chair of the Clinical Practice Obstetrics Committee of the SOGC, he participated in the production of Healthy Beginnings: Guidelines for Care during Pregnancy and Childbirth, the Policy Statement on Rural Obstetrics and the 2018 clinical practice guideline on Physiologic Basis of Pain in Labour and Delivery: An Evidence-Based Approach to its Management.

Disclosure

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose.

I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).